Activation-optimized anti-CD3 valency control enables combinatorial discovery of multi-specific nanoantibodies for solid tumor immunotherapy
Year: 2026
Type: article
Source: 中国科学通报:英文版
Institution: South China University of Technology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Awards: G3261970015, G7367485750, G7437773990
OpenAlex ID: W7204808085
